Skin and Collagen Research Protocol
GHK-Cu and Epithalon for combined ECM remodeling and cellular senescence research in skin aging models
The Skin and Collagen Research Protocol pairs GHK-Cu, the most extensively studied copper-binding tripeptide for collagen synthesis and extracellular matrix remodeling, with Epithalon, a telomerase-activating tetrapeptide that addresses the cellular senescence dimension of skin aging. Skin aging operates simultaneously at the tissue level, through declining collagen synthesis, increasing MMP activity, and reduced fibroblast productivity, and at the cellular level, through replicative senescence of fibroblast and keratinocyte populations. GHK-Cu targets the tissue and matrix level, while Epithalon targets the cellular longevity level, making their combination relevant to researchers studying age-related skin biology from both perspectives.
Stack Compounds
Each compound contributes a distinct mechanism to the combined research protocol.
GHK-Cu
Provides the collagen synthesis, MMP modulation, and extracellular matrix remodeling component of the protocol, targeting fibroblast activity directly in dermal tissue models.
Epithalon
Provides the cellular longevity and anti-senescence component, activating telomerase to extend fibroblast replicative capacity and modulate cellular aging at the gene expression level.
Why This Combination Works
GHK-Cu and Epithalon address skin aging at different biological levels. GHK-Cu acts at the tissue and matrix level by directly stimulating fibroblast collagen production and modulating the enzymes that degrade the matrix. Epithalon acts at the cellular level by activating telomerase, which can extend the replicative lifespan of the fibroblast populations responsible for synthesizing that matrix. Longer-lived fibroblasts with better telomere maintenance may sustain collagen synthesis capacity for more cell divisions, creating a potential interaction between the two mechanisms that is relevant to skin aging research.
Research Context
Skin aging research has increasingly recognized that both matrix-level and cellular-level interventions are necessary to address the full scope of age-related dermal decline. GHK-Cu research dates to the 1970s with Pickart et al. and has the most extensive skin-specific literature of any compound in this protocol. Epithalon adds the cellular longevity dimension that has emerged as a complementary target in aging skin biology, particularly as the role of fibroblast senescence in skin aging has been increasingly characterized.
Related Compound Comparisons
Side-by-side mechanism comparisons for compounds in this stack.
Related Research Use Cases
Explore the broader research contexts this stack contributes to.
Frequently Asked Questions
Build This Stack
All compounds in this stack are available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.